Raymond James Trust’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-22,808
| Closed | -$492K | – | 1278 |
|
2023
Q4 | $492K | Sell |
22,808
-1,000
| -4% | -$21.6K | 0.01% | 705 |
|
2023
Q3 | $443K | Buy |
23,808
+764
| +3% | +$14.2K | 0.01% | 698 |
|
2023
Q2 | $583K | Buy |
23,044
+1,525
| +7% | +$38.6K | 0.02% | 601 |
|
2023
Q1 | $557K | Buy |
21,519
+4,768
| +28% | +$123K | 0.02% | 589 |
|
2022
Q4 | $396K | Buy |
16,751
+3,329
| +25% | +$78.7K | 0.01% | 701 |
|
2022
Q3 | $340K | Buy |
13,422
+523
| +4% | +$13.2K | 0.01% | 735 |
|
2022
Q2 | $428K | Buy |
12,899
+1,448
| +13% | +$48K | 0.02% | 641 |
|
2022
Q1 | $826K | Buy |
11,451
+827
| +8% | +$59.7K | 0.03% | 466 |
|
2021
Q4 | $976K | Sell |
10,624
-656
| -6% | -$60.3K | 0.03% | 435 |
|
2021
Q3 | $1.43M | Buy |
11,280
+309
| +3% | +$39.2K | 0.05% | 310 |
|
2021
Q2 | $1.82M | Sell |
10,971
-34
| -0.3% | -$5.65K | 0.06% | 267 |
|
2021
Q1 | $2M | Buy |
11,005
+632
| +6% | +$115K | 0.07% | 241 |
|
2020
Q4 | $2.07M | Sell |
10,373
-293
| -3% | -$58.6K | 0.08% | 219 |
|
2020
Q3 | $2.34M | Buy |
10,666
+256
| +2% | +$56.1K | 0.1% | 176 |
|
2020
Q2 | $1.99M | Buy |
10,410
+844
| +9% | +$161K | 0.1% | 183 |
|
2020
Q1 | $1.48M | Buy |
9,566
+155
| +2% | +$24K | 0.09% | 202 |
|
2019
Q4 | $788K | Buy |
9,411
+25
| +0.3% | +$2.09K | 0.04% | 358 |
|
2019
Q3 | $635K | Buy |
9,386
+726
| +8% | +$49.1K | 0.03% | 394 |
|
2019
Q2 | $575K | Hold |
8,660
| – | – | 0.03% | 404 |
|
2019
Q1 | $482K | Sell |
8,660
-373
| -4% | -$20.8K | 0.03% | 434 |
|
2018
Q4 | $448K | Buy |
9,033
+1,089
| +14% | +$54K | 0.03% | 419 |
|
2018
Q3 | $686K | Buy |
7,944
+100
| +1% | +$8.64K | 0.04% | 353 |
|
2018
Q2 | $455K | Sell |
7,844
-143
| -2% | -$8.3K | 0.03% | 443 |
|
2018
Q1 | $322K | Sell |
7,987
-1,735
| -18% | -$69.9K | 0.02% | 504 |
|
2017
Q4 | $339K | Sell |
9,722
-221
| -2% | -$7.71K | 0.02% | 505 |
|
2017
Q3 | $330K | Buy |
9,943
+2,643
| +36% | +$87.7K | 0.02% | 504 |
|
2017
Q2 | $253K | Buy |
+7,300
| New | +$253K | 0.02% | 580 |
|